Qube Research & Technologies (QRT)
GSK icon

Qube Research & Technologies (QRT)’s GSK GSK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.5M Buy
1,078,767
+530,545
+97% +$28.1M 0.05% 457
2026
Q1 		$30.3M Buy
+548,222
New +$29.7M 0.03% 646
2024
Q4 		– Sell
-107,377
Closed -$3.87M – 3603
2024
Q3 		$4.39M Sell
107,377
-162,717
-60% -$6.66M 0.01% 1450
2024
Q2 		$10.4M Buy
+270,094
New +$11.4M 0.02% 902
2024
Q1 		– Sell
-432,648
Closed -$16M – 4627
2023
Q4 		$16M Buy
+432,648
New +$15.5M 0.03% 575
2023
Q2 		– Sell
-117,622
Closed -$4.18M – 2628
2023
Q1 		$4.18M Buy
117,622
+96,877
+467% +$3.39M 0.02% 723
2022
Q4 		$729K Sell
20,745
-750,678
-97% -$25M ﹤0.01% 1346
2022
Q3 		$22.7M Buy
+771,423
New +$29.2M 0.14% 209
2022
Q2 		– Sell
-298,593
Closed -$16.3M – 2748
2022
Q1 		$16.3M Buy
298,593
+246,835
+477% +$13.4M 0.14% 192
2021
Q4 		$2.85M Sell
51,758
-53,337
-51% -$2.77M 0.02% 709
2021
Q3 		$5.02M Buy
+105,095
New +$5.28M 0.06% 408
2021
Q2 		– Sell
-76,972
Closed -$3.43M – 2464
2021
Q1 		$3.43M Buy
76,972
+26,019
+51% +$1.18M 0.05% 457
2020
Q4 		$2.34M Sell
50,953
-53,768
-51% -$2.47M 0.03% 555
2020
Q3 		$4.93M Buy
104,721
+41,041
+64% +$2.06M 0.07% 360
2020
Q2 		$3.25M Buy
+63,680
New +$3.27M 0.05% 497
2020
Q1 		– Sell
-16,650
Closed -$978K – 1348
2019
Q4 		$978K Buy
+16,650
New +$926K 0.03% 624
2018
Q2 		– Sell
-21,678
Closed -$1.06M – 864
2018
Q1 		$1.06M Buy
+21,678
New +$1.01M 0.41% 37

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GSK Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its GSK (GSK) stake by 97% in Q2 2026, buying an estimated $28.1M and bringing the position to 1,078,767 shares worth $56.5M. The position accounts for 0.05% of the portfolio, ranked #457.

Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 17 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,078,767 shares of GSK worth $56.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 530,545 GSK shares in Q2 2026, an estimated $28.1M.
  • GSK made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #457 holding.
  • Qube Research & Technologies (QRT) first reported a position in GSK in Q1 2018 and has held it in 17 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.